Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer

Conclusion: Our data suggests that the use of anti-angiogenic drugs may not exacerbate COVID-19 severity in NSCLC patients, indicating their potential safe application even during the pandemic period.PMID:38656242 | DOI:10.1177/15330338241248573

Source: Cell Research - April 24, 2024 Category: Cytology Authors: Sujuan Peng Hongxiang Huang Jinhong Chen Xinjing Ding Xie Zhu Yangyang Liu Li Chen Zhihui Lu Source Type: research